Skip to main content
Full access
Letters to the Editor
Published Online: 1 June 2019

How Long Does Antidepressant Withdrawal Typically Last?

To the Editor: In the December 2018 issue of the Journal, Jha and colleagues (1) claim that antidepressant withdrawal typically resolves spontaneously over 2–3 weeks. They offer only three references in support. Two of these were case reports that included one and three patients (2, 3). In Pyke (3), the withdrawal reaction resolved in 3 weeks, whereas in the case report by Frost and Lal, withdrawal symptoms lasted between 3 and 23 weeks (2). The third reference, a small cohort study of 20 patients by Fava et al. (4), reported that a withdrawal reaction was observed in nine patients (45% of all patients examined), even though the drugs were tapered at the slowest possible pace. The withdrawal syndrome subsided within 4 weeks in six patients (67% of all patients experiencing withdrawal), whereas in three patients (33% of all patients with withdrawal), serious withdrawal symptoms persisted for several months after discontinuation.
Not only did Jha and colleagues select only three studies, representing a total of just 24 patients, but the three studies they present to readers as evidence for their 2–3 weeks claim do not actually support their claim at all. In Frost and Lal (2), the three individual withdrawal reactions described lasted between 3 and 23 weeks, and in Fava et al. (4), withdrawal effects lasted considerably longer than 4 weeks in one-third of patients. Based on this evidence, the conclusion that withdrawal reactions “typically resolve spontaneously over 2–3 weeks” is fallacious and arbitrary. Moreover, two references were merely case reports, which have very little external validity. In our view, it is problematic to quote (or, rather, misquote) such anecdotal evidence to corroborate a controversial claim that should represent the broader antidepressant user population. Although there undoubtedly is a need for more research on this important issue, systematic reviews of the existing literature conclude that withdrawal is common, is often severe, and frequently lasts much longer than merely 2–3 weeks, with and without tapering (5, 6).

References

1.
Jha MK, Rush AJ, Trivedi MH: When discontinuing SSRI antidepressants is a challenge: management tips. Am J Psychiatry 2018; 175:1176–1184
2.
Frost L, Lal S: Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors (letter). Am J Psychiatry 1995; 152:810
3.
Pyke RE: Paroxetine withdrawal syndrome (letter). Am J Psychiatry 1995; 152:149–150
4.
Fava GA, Bernardi M, Tomba E, et al: Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Int J Neuropsychopharmacol 2007; 10:835–838
5.
Davies J, Read J: A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addict Behav (Epub ahead of print, Sept 4, 2018)
6.
Fava GA, Gatti A, Belaise C, et al: Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84:72–81

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 487
PubMed: 31154817

History

Accepted: 8 April 2019
Published online: 1 June 2019
Published in print: June 01, 2019

Keywords

  1. Antidepressants
  2. Drug Side Effects-Other
  3. Discontinuation
  4. Selective Serotonin Reuptake Inhibitors

Authors

Affiliations

Michael P. Hengartner, Ph.D. [email protected]
School of Applied Psychology, Zurich University of Applied Sciences, Zurich (Hengartner); University of Roehampton, London, and All-Party Parliamentary Group for Prescribed Drug Dependence, London (Davies); School of Psychology, University of East London, London, and International Institute for Psychiatric Drug Withdrawal, Gothenberg, Sweden (Read).
James Davies, Ph.D.
School of Applied Psychology, Zurich University of Applied Sciences, Zurich (Hengartner); University of Roehampton, London, and All-Party Parliamentary Group for Prescribed Drug Dependence, London (Davies); School of Psychology, University of East London, London, and International Institute for Psychiatric Drug Withdrawal, Gothenberg, Sweden (Read).
John Read, Ph.D.
School of Applied Psychology, Zurich University of Applied Sciences, Zurich (Hengartner); University of Roehampton, London, and All-Party Parliamentary Group for Prescribed Drug Dependence, London (Davies); School of Psychology, University of East London, London, and International Institute for Psychiatric Drug Withdrawal, Gothenberg, Sweden (Read).

Notes

Send correspondence to Dr. Hengartner ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share